Top Markets
#1 MowCat MowCat +48.44%
#2 Bermuda Shorts Bermuda Shorts +26.43%
#3 Velvet Velvet +25.14%
#4 Quack AI Quack AI +18.37%
#5 Biconomy Biconomy +18.22%
#6 Derive Derive +17.09%
#7 Block Street Block Street +15.53%
#8 DUSK Network DUSK Network +14.69%
#9 Perle Perle +14.22%
#10 Zerebro Zerebro +14.22%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cellyan Biotechnology Co., Ltd Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPD
Rangering i aksjer #34988
Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily... Cellyan Biotechnology Co., Ltd, an investment holding entity, primarily operates within the over-the-counter (OTC) pharmaceutical sector, serving markets across Hong Kong and mainland China. The company's services encompass the international sourcing and distribution of OTC medications, alongside comprehensive e-commerce supply chain management. Furthermore, it provides essential logistical support, including customs clearance, drug registration, and warehousing facilities. Cellyan Biotechnology caters to a diverse clientele, which includes logistics partners for e-commerce platforms, various merchants, and pharmaceutical distributors. Founded in 2023, the company is based in Yau Tong, Hong Kong. It was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and officially adopted the name Cellyan Biotechnology Co., Ltd in December 2025.
Aksjekurs
$0.422
Sist synkronisert: 2026-08-14
Markedsverdi
$4.63M
Endring (1 dag)
0.48%
Endring (1 år)
-60.56%
Land
HK
Handel Cellyan Biotechnology Co., Ltd (HKPD)

Kategori

Healthcare
Inntekter for Cellyan Biotechnology Co., Ltd (HKPD)
Inntekter i 2026 TTM: 0
Ifølge Cellyan Biotechnology Co., Ltd sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Cellyan Biotechnology Co., Ltd fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US